Skip to Menu Skip to Search Contact Us Skip to Content
US Flag

You are accessing SGS’s website from the USA.

Visit the US website instead

Stay on the global website and remember my choice

Nucleic Acid Amplification Techniques

Biosafety is of utmost concern in bio-therapeutic and vaccine manufacturing, especially because of the increasing rate of discovery of previously unrecognized viruses. Viral contamination from animal products and raw materials represents a significant–and growing– threat to biotechnology products. Importantly, additional steps to detect viral contamination need to be incorporated to ensure safety.

Now that streamlined assay validation procedures and GMP-validated Nucleic Acid Amplification Techniques (NAT) tests are readily available, these methods provide manufacturers with the confidence required in production and batch release of products. The high reproducibility and fast throughput of cutting-edge NATs reduces the amount of time needed for development, safety testing, and final marketing of novel biotechnology products.

Please complete the form to download your copy.

Fields marked with an asterisk (*) are mandatory.

White paper request form

Are you an SGS client?*

200 characters remaining